This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jan 7;37(2):198-9.

doi: 10.1093/eurheartj/ehv469. Epub 2015 Sep 2.

Discontinuation of P2Y12 antagonists before coronary bypass surgery: is 5 days really required?

Franz Weidinger¹

Affiliations

PMID: 26333369
DOI: 10.1093/eurheartj/ehv469

Editorial

Discontinuation of P2Y12 antagonists before coronary bypass surgery: is 5 days really required?

Franz Weidinger. Eur Heart J. 2016.

. 2016 Jan 7;37(2):198-9.

doi: 10.1093/eurheartj/ehv469. Epub 2015 Sep 2.

Author

Franz Weidinger¹

Affiliation

¹ Rudolfstiftung Hospital, Vienna, Austria franz.weidinger@wienkav.at.

PMID: 26333369
DOI: 10.1093/eurheartj/ehv469

No abstract available

PubMed Disclaimer

Comment on

Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
Hansson EC, Jidéus L, Åberg B, Bjursten H, Dreifaldt M, Holmgren A, Ivert T, Nozohoor S, Barbu M, Svedjeholm R, Jeppsson A. Hansson EC, et al. Eur Heart J. 2016 Jan 7;37(2):189-97. doi: 10.1093/eurheartj/ehv381. Epub 2015 Sep 1. Eur Heart J. 2016. PMID: 26330426 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information